The effect of calcium supplements on troponin variables in athletes and their association with bone diseases : Implications for myocardial health

Abstract

Calcium supplements are commonly used by athletes, and they are also used to treat certain bone ailments, however their cardiovascular safety is still debated. This study was designed to investigate the effect of calcium supplements on troponin variables in athletes as well as those with bone diseases. The current study is case control research included 180 participants (60 patients with bone problems, 60 athletes who use calcium supplements, and 60 healthy control subjects who do not take calcium supplements) and the levels of calcium and troponin measured for all subjected group. The results showed that serum calcium levels in athlete's participants were significantly higher than patients with bone diseases and healthy control subjects respectively (10.13 ± 1.2 vs 9.62 ± 0.92 and 8.57± 0.64, respectively). Also, the calcium levels in patients with bone diseases was significantly higher than healthy control subjects P< 0.001). Serum Troponine concentrations in patients with bone diseasesi and athletes participants were significantly higher than controls (0.22 ± 0.07 and 0.21 ± 0.07 vs 0.06 ± 0.01, respectively, P>0.001). Results showed that the Troponin levels correlate directly with serum calcium among study group which might be referred to that this condition enhances production of Troponin in relation to serum calcium which in turn affected by the calcium supplement administered that linked to a higher risk of myocardial infarction which lead to conclude that it is important to utilize calcium supplements sparingly and aim to get the majority of the necessary daily intake of calcium from food sources.

Keywords

• Cardiac troponin
• bone
• calcium supplements
• myocardium

References

1. Kunstel K. Calcium requirements for the athlete. Curr Sports Med Rep. 2005;4(4):203-206. https://doi.org/10.1097/01.csmr.0000306208.56939.01
2. Reid IR, Birstow SM, Bolland MJ. Calcium and Cardiovascular Disease. Endocrinol Metab (Seoul). 2017;32(3):339- 349. https://doi.org/10.3803/enm.2017.32.3.339
3. Eisner DA, Caldwell JL, Kistamás K, Trafford AW. Calcium and Excitation-Contraction Coupling in the Heart. Circ Res. 2017;121(2):181-195. https://doi.org/10.1161/circresaha.117.310230
4. Sweeney HL, Brito RM, Rosevear PR, Putkey JA. The low-affinity Ca2(+)-binding sites in cardiac/slow skeletal muscle troponin C perform distinct functions: site I alone cannot trigger contraction. Proc Natl Acad Sci U S A. 1990;87(24):9538-9542. https://doi.org/10.1073/pnas.87.24.9538
5. Kozinski M, Krintus M, Kubica J, Sypniewska G. High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification. Crit Rev Clin Lab Sci. 2017;54(3):143-172. https://doi.org/10.1080/10408363.2017.1285268
6. Tobacman LS. Troponin Revealed: Uncovering the Structure of the Thin Filament On-Off Switch in Striated Muscle. Biophys J. 2021;120(1):1-9. https://doi.org/10.1016/j.bpj.2020.11.014
7. Lazar DR, Lazar FL, Homorodean C, Cainap C, Focsan M, Cainap S, Olinic DM. High-Sensitivity Troponin: A Review on Characteristics, Assessment, and Clinical Implications. Dis Markers. 2022;2022:9713326. https://doi.org/10.1155/2022/9713326
8. Jarari AM, Farag AMMM, Abdulamir HA, Pathak RM. Ferritin Levels and Erythrocyte Lipid Peroxidation in Acute Myocardial Infarction in Diabetic Patients. Jamahiriya Med J. 2010;10(2):101-105.

9. Al-Shammari AH, Abbood ZA, Lateef HF. Assessing the impacts of L-carnitine and modafinil on fatigue in Iraqi multiple sclerosis patients. J Adv Pharm Technol Res. 2023;14(3):226-228. https://doi.org/10.4103%2FJAPTR.JAPTR_225_23
10. Parmacek MS, Solaro RJ. Biology of the troponin complex in cardiac myocytes. Prog Cardiovasc Dis. 2004;47(3):159- 176. https://doi.org/10.1016/j.pcad.2004.07.003
11. Kuo IY, Ehrlich BE. Signaling in muscle contraction. Cold Spring Harb Perspect Biol. 2015;7(2):a006023. https://doi.org/10.1101/cshperspect.a006023
12. AL-SHAMMARI AH, SHANDOOKH QJ. Efficacy of statin therapy on achieving target goal of LDL among Iraqi patients. Acta Pharm Sci. 2024;62(2):278-287. http://dx.doi.org/10.23893/1307-2080.APS6218
13. Saunders RK, Kilroe KM, Joseph TV, Caksa S, Bouxsein ML, Misra M, Mitchell DM. Total Calcium Intake Is Associated With Trabecular Bone Density in Adolescent Girls With Type 1 Diabetes. JBMR Plus. 2023;7(11):e10813. https://doi.org/10.1002/jbm4.10813
14. Morelli MB, Santulli G, Gambardella J. Calcium supplements: Good for the bone, bad for the heart? A systematic updated appraisal. Atherosclerosis. 2020;296:68-73. https://doi.org/10.1016/j.atherosclerosis.2020.01.008
15. Reid IR, Bristow SM, Bolland MJ. Cardiovascular complications of calcium supplements. J Cell Biochem. 2015;116(4):494-501. https://doi.org/10.1002/jcb.25028
16. Malczewska-Lenczowska J, Surała O, Granda D, Szczepańska B, Czaplicki A, Kubacki R. The Relationship between Bone Health Parameters, Vitamin D and Iron Status, and Dietary Calcium Intake in Young Males. Nutrients. 2024;16(2):215. https://doi.org/10.3390/nu16020215
17. Shin CS, Kim KM. The risks and benefits of calcium supplementation. Endocrinol Metab (Seoul). 2015;30(1):27-34. https://doi.org/10.3803/enm.2015.30.1.27
18. Reid IR. Cardiovascular effects of calcium supplements. Nutrients. 2013;5(7):2522-2529. https://doi.org/10.3390/nu5072522
19. Myung SK, Kim HB, Lee YJ, Choi YJ, Oh SW. Calcium Supplements and Risk of Cardiovascular Disease: A Meta- Analysis of Clinical Trials. Nutrients. 2021;13(2):368. https://doi.org/10.3390/nu13020368
20. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. Bmj. 2011;342:d2040. https://doi.org/10.1136/bmj.d2040
21. liu Y, Le S, Liu Y, Jiang H, Ruan B, Huang Y, Ao X, Shi X, Fu X, Wang S. The effect of calcium supplementation in people under 35 years old: A systematic review and meta-analysis of randomized controlled trials. Elife. 2022;11:e79002. https://doi.org/10.7554/eLife.79002
22. Li K, Wang XF, Li DY, Chen YC, Zhao LJ, Liu XG, Guo YF, Shen J, Lin X, Deng J, Zhou R, Deng HW. The good, the bad, and the ugly of calcium supplementation: a review of calcium intake on human health. Clin Interv Aging. 2018;13:2443-2452. https://doi.org/10.2147/cia.s157523
23. Tankeu AT, Ndip Agbor V, Noubiap JJ. Calcium supplementation and cardiovascular risk: A rising concern. J Clin Hypertens (Greenwich). 2017;19(6):640-646. https://doi.org/10.1111/jch.13010
24. Larsson SC, Butterworth AS, Burgess S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J. 2023;44(47):4913-4924. https://doi.org/10.1093/eurheartj/ehad736
25. Manna MJ, Jabur MS, Mohammad HR, Abdulamir HA. The potential effect of topical aminophylline on acute glaucoma model. Res J Pharm Technol. 2022; 15(1):197-200. http://dx.doi.org/10.52711/0974-360X.2022.00032
26. Aldafaay AAA, Abdulamir HA, Abdulhussain HA, Badry AS, Abdulsada AK. The use of Urinary α-amylase level in a diagnosis of chronic renal failure. Res J Pharm Technol. 2021; 14(3):1597-1600. http://dx.doi.org/10.5958/0974- 360X.2021.00283.3